ArticleJBMR plus2025

Sodium-glucose co-transporter-2 inhibitors vs metformin in reducing osteoarthritis risk: a retrospective cohort study of health insurance claims and check-up data.

Masaki Hatano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.